Company Filing History:
1 out of 832,812 Years Active: 2003
Title: Irman Gard Sures: Innovator in Megakaryocyte Kinases
Introduction
Irman Gard Sures is a notable inventor based in Munich, Germany. He has made significant contributions to the field of cellular signal transduction through his innovative research and patents. His work focuses on novel cytoplasmic tyrosine kinases isolated from megakaryocytes, which play a crucial role in various biological processes.
Latest Patents
Irman Gard Sures holds a patent titled "Nucleotide encoding megakaryocytic protein tyrosine kinases." This invention relates to the discovery of novel proteins known as megakaryocyte kinases (MKKs), which are involved in cellular signal transduction pathways. The patent outlines the use of these proteins in the diagnosis and treatment of diseases. Specifically, it highlights three megakaryocyte kinases designated as MKK1, MKK2, and MKK3, which can serve as diagnostic and therapeutic agents. He has 1 patent to his name.
Career Highlights
Throughout his career, Irman Gard Sures has focused on advancing the understanding of megakaryocyte kinases and their applications in medicine. His research has the potential to impact the diagnosis and treatment of various diseases, showcasing his commitment to innovation in the biomedical field.
Collaborations
Irman Gard Sures has collaborated with esteemed colleagues, including Axel Ullrich and Mikhail L Gishizky. These partnerships have further enriched his research and contributed to the advancement of knowledge in the field of protein tyrosine kinases.
Conclusion
Irman Gard Sures is a pioneering inventor whose work on megakaryocyte kinases has opened new avenues for medical research and treatment. His contributions are significant in the realm of cellular biology and therapeutic development.